 | • レポートコード：QYR2104Z3678 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、黒色腫がん診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（蛍光insituハイブリダイゼーション（FISH）検査、比較ゲノムハイブリダイゼーション（CGH）検査、免疫組織化学（IHC）検査）、用途別市場規模（病院、クリニック、がん研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・黒色腫がん診断の市場動向 ・企業の競争状況、市場シェア ・黒色腫がん診断の種類別市場規模（蛍光insituハイブリダイゼーション（FISH）検査、比較ゲノムハイブリダイゼーション（CGH）検査、免疫組織化学（IHC）検査） ・黒色腫がん診断の用途別市場規模（病院、クリニック、がん研究センター、その他） ・黒色腫がん診断の北米市場規模2016-2027（アメリカ、カナダ） ・黒色腫がん診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・黒色腫がん診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・黒色腫がん診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・黒色腫がん診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AB Sciences、Incyte、Merck、Novartis、Pierre Fabre、Amgen、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo） ・結論 |
Melanoma is a type of skin cancer developing from pigment-containing cells known as melanocytes. Melanoma cancer diagnostics is to diagnose melanoma with biopsy. During a biopsy, all or the part of mole or growth over the skin is removed to test and analyze the sample. Common biopsy procedures used to diagnose melanoma are punch biopsy, incisional biopsy, and excisional biopsy.
Market Analysis and Insights: Global Melanoma Cancer Diagnostics Market
The global Melanoma Cancer Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanoma Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanoma Cancer Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanoma Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanoma Cancer Diagnostics market.
Global Melanoma Cancer Diagnostics Scope and Market Size
Melanoma Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Fluorescent In Situ Hybridization (FISH) Tests
Comparative Genomic Hybridization (CGH) Tests
Immunohistochemical (IHC) Tests
Segment by Application
Hospitals
Clinics
Cancer Research Centres
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fluorescent In Situ Hybridization (FISH) Tests
1.2.3 Comparative Genomic Hybridization (CGH) Tests
1.2.4 Immunohistochemical (IHC) Tests
1.3 Market by Application
1.3.1 Global Melanoma Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Cancer Diagnostics Market Perspective (2016-2027)
2.2 Melanoma Cancer Diagnostics Growth Trends by Regions
2.2.1 Melanoma Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Melanoma Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Melanoma Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Melanoma Cancer Diagnostics Industry Dynamic
2.3.1 Melanoma Cancer Diagnostics Market Trends
2.3.2 Melanoma Cancer Diagnostics Market Drivers
2.3.3 Melanoma Cancer Diagnostics Market Challenges
2.3.4 Melanoma Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Cancer Diagnostics Players by Revenue
3.1.1 Global Top Melanoma Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Melanoma Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Melanoma Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Melanoma Cancer Diagnostics Revenue
3.4 Global Melanoma Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Melanoma Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Diagnostics Revenue in 2020
3.5 Melanoma Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Melanoma Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Melanoma Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Cancer Diagnostics Breakdown Data by Type
4.1 Global Melanoma Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Melanoma Cancer Diagnostics Forecasted Market Size by Type (2022-2027)
5 Melanoma Cancer Diagnostics Breakdown Data by Application
5.1 Global Melanoma Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Melanoma Cancer Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Melanoma Cancer Diagnostics Market Size (2016-2027)
6.2 North America Melanoma Cancer Diagnostics Market Size by Type
6.2.1 North America Melanoma Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Melanoma Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Melanoma Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America Melanoma Cancer Diagnostics Market Size by Application
6.3.1 North America Melanoma Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Melanoma Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Melanoma Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America Melanoma Cancer Diagnostics Market Size by Country
6.4.1 North America Melanoma Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Melanoma Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Melanoma Cancer Diagnostics Market Size (2016-2027)
7.2 Europe Melanoma Cancer Diagnostics Market Size by Type
7.2.1 Europe Melanoma Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Melanoma Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Melanoma Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe Melanoma Cancer Diagnostics Market Size by Application
7.3.1 Europe Melanoma Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Melanoma Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Melanoma Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe Melanoma Cancer Diagnostics Market Size by Country
7.4.1 Europe Melanoma Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Melanoma Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Melanoma Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America Melanoma Cancer Diagnostics Market Size by Type
9.2.1 Latin America Melanoma Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Melanoma Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Melanoma Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Melanoma Cancer Diagnostics Market Size by Application
9.3.1 Latin America Melanoma Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Melanoma Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Melanoma Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Melanoma Cancer Diagnostics Market Size by Country
9.4.1 Latin America Melanoma Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Melanoma Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB Sciences
11.1.1 AB Sciences Company Details
11.1.2 AB Sciences Business Overview
11.1.3 AB Sciences Melanoma Cancer Diagnostics Introduction
11.1.4 AB Sciences Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.1.5 AB Sciences Recent Development
11.2 Incyte
11.2.1 Incyte Company Details
11.2.2 Incyte Business Overview
11.2.3 Incyte Melanoma Cancer Diagnostics Introduction
11.2.4 Incyte Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.2.5 Incyte Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Melanoma Cancer Diagnostics Introduction
11.3.4 Merck Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Melanoma Cancer Diagnostics Introduction
11.4.4 Novartis Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pierre Fabre
11.5.1 Pierre Fabre Company Details
11.5.2 Pierre Fabre Business Overview
11.5.3 Pierre Fabre Melanoma Cancer Diagnostics Introduction
11.5.4 Pierre Fabre Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.5.5 Pierre Fabre Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Melanoma Cancer Diagnostics Introduction
11.6.4 Amgen Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Melanoma Cancer Diagnostics Introduction
11.7.4 AstraZeneca Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Melanoma Cancer Diagnostics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Melanoma Cancer Diagnostics Introduction
11.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Diagnostics Business (2016-2021)
11.9.5 Daiichi Sankyo Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Melanoma Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fluorescent In Situ Hybridization (FISH) Tests
Table 3. Key Players of Comparative Genomic Hybridization (CGH) Tests
Table 4. Key Players of Immunohistochemical (IHC) Tests
Table 5. Global Melanoma Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Melanoma Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Melanoma Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Melanoma Cancer Diagnostics Market Share by Regions (2016-2021)
Table 9. Global Melanoma Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Melanoma Cancer Diagnostics Market Share by Regions (2022-2027)
Table 11. Melanoma Cancer Diagnostics Market Trends
Table 12. Melanoma Cancer Diagnostics Market Drivers
Table 13. Melanoma Cancer Diagnostics Market Challenges
Table 14. Melanoma Cancer Diagnostics Market Restraints
Table 15. Global Melanoma Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Melanoma Cancer Diagnostics Market Share by Players (2016-2021)
Table 17. Global Top Melanoma Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Cancer Diagnostics as of 2020)
Table 18. Ranking of Global Top Melanoma Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Melanoma Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Melanoma Cancer Diagnostics Product Solution and Service
Table 22. Date of Enter into Melanoma Cancer Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Melanoma Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Melanoma Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 26. Global Melanoma Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Melanoma Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Melanoma Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Melanoma Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 30. Global Melanoma Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Melanoma Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Melanoma Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Melanoma Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Melanoma Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Melanoma Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Melanoma Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Melanoma Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Melanoma Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Melanoma Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Melanoma Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Melanoma Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Melanoma Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Melanoma Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Melanoma Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Melanoma Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Melanoma Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Melanoma Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Melanoma Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Melanoma Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 62. AB Sciences Company Details
Table 63. AB Sciences Business Overview
Table 64. AB Sciences Melanoma Cancer Diagnostics Product
Table 65. AB Sciences Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 66. AB Sciences Recent Development
Table 67. Incyte Company Details
Table 68. Incyte Business Overview
Table 69. Incyte Melanoma Cancer Diagnostics Product
Table 70. Incyte Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 71. Incyte Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Melanoma Cancer Diagnostics Product
Table 75. Merck Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Melanoma Cancer Diagnostics Product
Table 80. Novartis Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Pierre Fabre Company Details
Table 83. Pierre Fabre Business Overview
Table 84. Pierre Fabre Melanoma Cancer Diagnostics Product
Table 85. Pierre Fabre Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 86. Pierre Fabre Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Melanoma Cancer Diagnostics Product
Table 90. Amgen Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Melanoma Cancer Diagnostics Product
Table 95. AstraZeneca Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Bristol-Myers Squibb Company Details
Table 98. Bristol-Myers Squibb Business Overview
Table 99. Bristol-Myers Squibb Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. Daiichi Sankyo Company Details
Table 102. Daiichi Sankyo Business Overview
Table 103. Daiichi Sankyo Melanoma Cancer Diagnostics Product
Table 104. Daiichi Sankyo Revenue in Melanoma Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 105. Daiichi Sankyo Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Fluorescent In Situ Hybridization (FISH) Tests Features
Figure 3. Comparative Genomic Hybridization (CGH) Tests Features
Figure 4. Immunohistochemical (IHC) Tests Features
Figure 5. Global Melanoma Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Research Centres Case Studies
Figure 9. Others Case Studies
Figure 10. Melanoma Cancer Diagnostics Report Years Considered
Figure 11. Global Melanoma Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Melanoma Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Melanoma Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Melanoma Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Melanoma Cancer Diagnostics Market Share by Players in 2020
Figure 16. Global Top Melanoma Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Cancer Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Melanoma Cancer Diagnostics Revenue in 2020
Figure 18. Global Melanoma Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Melanoma Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Melanoma Cancer Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Melanoma Cancer Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Melanoma Cancer Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Melanoma Cancer Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Melanoma Cancer Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Melanoma Cancer Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Melanoma Cancer Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Melanoma Cancer Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Melanoma Cancer Diagnostics Market Share by Region (2016-2027)
Figure 40. China Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Melanoma Cancer Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Melanoma Cancer Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Melanoma Cancer Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Melanoma Cancer Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Melanoma Cancer Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Melanoma Cancer Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Melanoma Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AB Sciences Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 60. Incyte Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 63. Pierre Fabre Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 67. Daiichi Sankyo Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の子宮頸がん診断検査市場規模・現状・予測（2021年-2027年） Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Market Analysis and Insights: Global Cervical Cancer Diagnostic Tests Market The global Cervical Cancer Diagnostic Tests market size is…- 世界の肺がん診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界の黒色腫がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Melanoma Cancer Market The global Melanoma Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a bri…
- 世界の蛍光in situハイブリダイゼーションプローブ市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Fluorescent in Situ Hybridization Probe Market The global Fluorescent in Situ Hybridization Probe market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の乳がんスクリーニング検査市場規模・現状・予測（2021年-2027年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…